Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ILDR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HMGB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MSN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD52 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
H6PD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAV2-AS5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGPEP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSEN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CENPI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMARCA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TP53I11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGFB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPT8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927876 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLIT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on